GRIFOLS, S.A. «...16» Page 16 out of 16 20/07/2020 08:12 GRIFOLS, S.A. On corporate transactions Grifols has executed share purchase arrangements with the South Korean based GC Pharma to purchase a plasma fractionation facility and two purification facilities located in Canada and 11 plasma collection centres located in the US Register number: 3479 07/05/2020 17:30 GRIFOLS, S.A. Other relevant information GRIFOLS informs that today it has signed with banks that were part of its debt refinancing in November 2019 an upsize of its multicurrency Revolving Credit Facility from $500 million to $1,000 million. Register number: 2095 21/04/2020 08:31 GRIFOLS, S.A. Interim management report La sociedad remite declaración intermedia de gestión del primer trimestre de 2020 Register number: 1657 03/04/2020 11:40 GRIFOLS, S.A. Board of Directors Regulations La sociedad remite el reglamento del Consejo de Administración Register number: 1380 27/02/2020 08:25 GRIFOLS, S.A. On business and financial situation Second half earnings report 2019 Register number: 391 27/02/2020 08:21 GRIFOLS, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del segundo semestre de 2019 Register number: 390 21/02/2020 13:17 GRIFOLS, S.A. Annual report on directors´ remunerations La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2019 Register number: 178 21/02/2020 13:08 GRIFOLS, S.A. Annual corporate governance report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2019 Register number: 176 18/02/2020 13:02 GRIFOLS, S.A. On corporate transactions Grifols has executed a non-binding term sheet with the Public Investment Fund of the Kingdom of Saudi Arabia. Register number: 122 Page 16 out of 16 «...16»
